Skip to main content

TV 7314 (Clopidogrel Bisulfate 75 mg (base))

Pill with imprint TV 7314 is Pink, Capsule-shape and has been identified as Clopidogrel Bisulfate 75 mg (base). It is supplied by Teva Pharmaceuticals, USA Inc.

Clopidogrel is used in the treatment of ischemic stroke; heart attack; acute coronary syndrome; acute coronary syndrome, prophylaxis; ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for TV 7314

Clopidogrel Bisulfate

TV 7314
75 mg (base)
13.00 mm
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals, USA Inc.
National Drug Code (NDC)
Inactive Ingredients
hydrogenated cottonseed oil, hypromellose 2910 (15 mPa.s), indigotindisulfonate sodium, FD&C Blue No. 2, ferric oxide red, ferric oxide yellow, lactose monohydrate, microcrystalline cellulose, polyethylene glycol 4000, sodium lauryl sulfate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.